BackgroundNumerous studies have verified that insomnia is associated with suicidal ideation, suicide attempts, and death by suicide. Limited population-based cohort studies have been conducted to examine the association. The present study aimed to analyze whether insomnia increases the risk of suicide attempts and verify the effects of insomnia on suicide risk.MethodsThis study is a cohort study using 2000–2013 hospitalization data from the National Health Insurance Research Database (NHIRD) to track the rate of suicide attempts among insomnia patients aged 15 years or older. In addition, a 1:2 pairing based on sex, age, and date of hospitalization was conducted to identify the reference cohort (patients without insomnia). Cox proportional hazard model was used to assess the effects of insomnia on suicide risk.ResultsThe total number of hospitalized patients aged 15 years or older was 479,967 between 2000 and 2013 (159,989 patients with insomnia and 319,978 patients without insomnia). After adjusting for confounders, suicide risk in insomnia patients was 3.533-fold that of patients without insomnia (adjusted hazard ratio [HR] = 3.533, 95% confidence interval [CI] = 3.059–4.080, P < 0.001). Suicide risk in low-income patients was 1.434-fold (adjusted HR = 1.434, 95% CI = 1.184–1.736, P < 0.001) that of non-low-income patients. Suicide risk in patients with drug dependence and with mental disorders was 1.592-fold (adjusted HR = 1.592, 95% CI = 1.220–2.077, P < 0.001) and 4.483-fold (adjusted HR = 4.483, 95% CI = 3.934–5.109, P < 0.001) that of patients without drug dependence and without mental disorders, respectively. In the female population, suicide risk in insomnia patients was 4.186-fold (adjusted HR = 4.186, 95% CI = 3.429–5.111, P < 0.001) that of patients without insomnia. Among patients aged 25–44 years, suicide risk in insomnia patients was 5.546-fold (adjusted HR = 5.546, 95% CI = 4.236–7.262, P < 0.001) that of patients without insomnia. Furthermore, the suicide risk of insomnia patients with mental disorders was 18.322-fold that of patients without insomnia and mental disorders (P < 0.001).ConclusionInsomnia, low income, drug dependence, and mental disorders are independent risk factors for suicide attempts. Female patients and those aged 25–44 years are at high risk of suicide due to insomnia. Insomnia, mental disorders, and low income exhibit a synergistic effect on suicide attempts. Clinicians should pay attention to mental status and income level of insomnia patients.Electronic supplementary materialThe online version of this article (10.1186/s12888-018-1702-2) contains supplementary material, which is available to authorized users.
IntroductionHfO 2 gate dielectrics are considered to be the most promising high-k dielectrics to meet the future ULSI application, due to its high dielectric constant and excellent thermal stability [1][2][3]. Besides, as MOS devices continue to be scaled down, the low supply voltage is desirable to minimize the power consumption. Dynamic threshold voltage (DT) MOSFET has been extensively studied [4], being attractive for lower power supply voltage applications. In addition, the CESL stressor [5][6] has been used to improve mobility in CMOS technology. However, the combination of DT and CESL nMOS with high-k in CMOS technology has yet to be proposed. In this work, the mechanism and reliability of DT-CESL-HfO 2 nMOSFETs were deeply investigated. Device PreparationA 0.35-μm process was used with local-oxidation-of-silicon (LOCOS) isolation. After standard RCA cleaning, the HfO 2 thin film with 1.6 nm (CET) was deposited on Si wafer. Then, α-Si (deposition at 550 o C,) of thickness 50 nm was deposited in order to get the local tensile strain n-channel [6], and the final poly-gate thickness was 150 nm. After the S/D formation, a low pressure chemical vapor deposition (LPCVD) 50 nm silicon nitride (CESL) was directly deposited on the transistor at 780 o C and followed by a 200 nm PE-SiO 2 deposition. After contact alignment, the PE-oxide and SiN layer on the S/D regions were etched in the same system. After these processes, a four-level metallization (Ti-TiN-Al-TiN) was carried out in the PVD system for the contact. Figure 1 shows the schematic diagram of DT-CESL-nMOS transistor with HfO 2 gate dielectric. As shown in Fig. 1, the poly-Si gate is directly connected to the p-well region. Figure 2 shows the I D -V D characteristics of the CESL strained HfO 2 nMOSFETs at normal and DT biasing, where the device channel length and width were 0.5 and 10 μm, respectively. The drain current of DT mode showed 133% increase over the normal mode for the CESL-device at V D = V G = V B = 0.7 V, as shown in Fig. 2. This large increase can be attributed to the body bias effect. For the DT mode, the device is in on-state. On the contrary, the device with normal operation is operated in depletion region. Figure 3 demonstrated the transconductance (g m ) of CESL-devices with different channel length, at DT and normal biasing, respectively. The g m under DT mode is larger than that under the normal mode. The enhancement of g m , compared to the normal operation mode, was increased, with channel length decreasing as shown in this figure. A roughly 138 % increase can be observed for the 0.35μm CESL-device at DT biasing, by comparison with the normal mode. On the other hand, the increase of g m was only about 40 % for the 1μm CESL-device. These results imply that the increase of electron mobility is different in different channel length for the DT-CESL-MOS with HfO 2 gate dielectrics. In addition, this performance enhancement of the DT-CESL-nMOS can be speculated to the inversion charge density increase at DT biasing, as shown in Fig. 4. T...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.